Rivaroxaban 366789-02-8 98%

The company has 2 manufacturing facilities in Solapur, Maharashtra. The flagship API facility is spread across 22 acre land in MIDC Chincholi, Solapur, and is WHO – GMP approved site by CDSCO. It has 7 manufacturing workshops and 8 clean rooms equipped with class 100000 air handling units. The current area occupied is about 50%, with ample free land available for future expansion. The second unit is a smaller facility with one workshop manufacturing intermediates for captive consumption.  

The company has more than 100 reactors with a mix of glass lined and SS 316 adding to an installed reactor capacity of more than 300 kilo liter. The company’s diverse equipment allows it to perform a variety of complex chemical reactions from -50 oC to over 250 oC and from low vacuum (1 mm) to high pressure (30 bar). The company is equally adept at handling both large volume (batch size of 1250 kg) and small volume (batch size 10 kg) manufacturing. The facility is a zero liquid discharge facility with integrated effluent treatment systems for complete recycling of water. 

The company has a state of the art quality control laboratory equipped with all testing facilities to release all our products in house. Our qualified and experienced quality assurance personnel ensure strict adherence to global GMP standards. Our strong regulatory affairs team is expert in providing timely documentation support to our clients and regulatory authorities across the globe.